日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Non-Small-Cell Lung Cancer Patients Harboring ROS1 Rearrangement: Real World Testing Practices, Characteristics and Treatment Patterns (ROS1REAL Study)

携带 ROS1 重排的非小细胞肺癌患者:真实世界的检测实践、特征和治疗模式(ROS1REAL 研究)

Janzic, Urska; Maimon Rabinovich, Natalie; Shalata, Walid; Kian, Waleed; Szymczak, Katarzyna; Dziadziuszko, Rafal; Jakopovic, Marko; Mountzios, Giannis; Pluzanski, Adam; Araujo, Antonio; Charpidou, Andriani; Daher, Sameh; Agbarya, Abed

Efficacy in patients with EGFR-positive non-small-cell lung cancer treated with dacomitinib who had skin adverse events: post hoc analyses from ARCHER 1050

接受达克替尼治疗的 EGFR 阳性非小细胞肺癌患者出现皮肤不良事件的疗效:ARCHER 1050 研究的事后分析

Pu, Xingxiang; Li, Juan; Zhang, Bo; Zhang, Jinyao; K Mok, Tony S; Nakagawa, Kazuhiko; Rosell, Rafael; Cheng, Ying; Zhou, Xiangdong; Miglorino, Maria Rita; Niho, Seiji; Lee, Ki Hyeong; Corral, Jesus; Pluzanski, Adam; Li, Junling; Linke, Rolf; Pan, Fang; Tang, Yiyun; Tan, Weiwei; Wu, Lin

Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer in CheckMate 227

CheckMate 227 研究比较了纳武利尤单抗联合伊匹木单抗与化疗作为转移性非小细胞肺癌一线治疗方案的五年生存结果。

Brahmer, Julie R; Lee, Jong-Seok; Ciuleanu, Tudor-Eliade; Bernabe Caro, Reyes; Nishio, Makoto; Urban, Laszlo; Audigier-Valette, Clarisse; Lupinacci, Lorena; Sangha, Randeep; Pluzanski, Adam; Burgers, Jacobus; Mahave, Mauricio; Ahmed, Samreen; Schoenfeld, Adam J; Paz-Ares, Luis G; Reck, Martin; Borghaei, Hossein; O'Byrne, Kenneth J; Gupta, Ravi G; Bushong, Judith; Li, Li; Blum, Steven I; Eccles, Laura J; Ramalingam, Suresh S

Nivolumab plus chemotherapy in first-line metastatic non-small-cell lung cancer: results of the phase III CheckMate 227 Part 2 trial

纳武利尤单抗联合化疗一线治疗转移性非小细胞肺癌:III期CheckMate 227第二部分试验结果

Borghaei, H; O'Byrne, K J; Paz-Ares, L; Ciuleanu, T-E; Yu, X; Pluzanski, A; Nagrial, A; Havel, L; Kowalyszyn, R D; Valette, C A; Brahmer, J R; Reck, M; Ramalingam, S S; Zhang, L; Ntambwe, I; Rabindran, S K; Nathan, F E; Balli, D; Wu, Y-L

1630P Effectivity and safety of anti-SARS-CoV2 vaccination in patients with lung cancer: The VAC-CaP observational study (GECP 21/01)

1630P 抗SARS-CoV-2疫苗在肺癌患者中的有效性和安全性:VAC-CaP观察性研究(GECP 21/01)

Hersby, D S; Do, T H; Gang, A O; Nielsen, T H; Ghiglione, L; Auclin, E; Aguilar-Company, J; Epaillard, N; Casadevall Aguilar, D; Masfarré, L; Rodriguez Castells, M; Tagliamento, M; Pilotto, S; Lopez Castro, R; Mielgo Rubio, X; Urbano Centella, C; Laguna, JC; García-Illescas, D; Bluthgen, MV; Gorría Puga, T; Minatta, JN; Cruz, CA; Prat, A; Mezquita, L; Soosaipillai, GB; Sureda, A; Maluquer Artigal, C; Benafif, S; Chopra, N; Harbeck, N; Wuerstlein, R; Mesia Nin, R; Felip, E; Ottaviani, D; Galazi, M; Lee, AJX; Salazar, R; Sharkey, R; Reyes, R; Evans, J; Carmona Garcia, MC; Tabernero, J; Prat, A; Pinato, DJ; Stewart, CA; Gay, C; Ramkumar, K; Cargill, KR; Cardnell, R; Nilsson, M; Heeke, S; Park, EM; Kundu, S; Diao, L; Wang, Q; Shen, L; Xi, Y; Della Corte, CM; Kundu, K; Gibbons, DL; Wang, J; Heymach, JV; Byers, LA; Agbarya, A; Addeo, A; Charpidou, A; Araújo, A; Cuppens, K; Brustugun, OT; Rajer, M; Jakopovic, M; Marinca, MV; Pluzanski, A; Marta, GDH; Auclin, E; Saoudi Gonzalez, N; Casadevall Aguilar, D; Rodriguez Castells, M; Epaillard, N; Tagliamento, M; Pilotto, S; López-Castro, R; Mielgo Rubio, X; Urbano Centella, C; Pineda, E; Laia, FM; Mirallas, O; Bluthgen, MV; Masfarré, L; Minatta, JN; Cruz, CA; Prat, A; Mezquita, L; Seguí, E; Auclin, E; Casadevall, D; Aguilar-Company, J; Rodriguez, M; Epaillard, N; Tagliamento, M; Pilotto, S; López-Castro, R; Mielgo, X; Urbano, C; Rodríguez, A; García-Illescas, D; Bluthgen, MV; Masfarré, L; Oliveres, H; Minatta, JN; Marco-Hernández, J; Prat, A; Mezquita, L; García-Illescas, D; Saoudi Gonzalez, N; Mirallas, O; Aguilar-Company, J; Ruiz-Camps, I; Garcia-Alvarez, A; Lostes Bardaji, MJ; Valdivia, A; Marmolejo Castaneda, DH; Rezqallah Aron, MA; López Valbuena, DE; Felip, E; Carles, J; Tabernero, J; Saura, C; Molinier, O; Falchero, L; Monnet, I; Decroisette, C; Neidhart, A-C; Redureau, E; Chiappa, A-M; Bigot, F; Bedossa, A; Amrane, K; Jeandeau, S; Dujon, C; Bugnet, A-S; Bonnefoy, P; Alizon, C; Meyer, N; Couraud, S; Cortot, A; Letierce, A; Debieuvre, D; Nadal, E; Moran Bueno, MT; Rodriguez Abreu, D; Vidales Sepulveda, Z; Sala Gonzalez, MA; Antonanzas Basa, M; Garcia Gonzalez, JJ; Diz Tain, P; Martinez Kareaga, M; Lopez Vivanco, G; Baena Espinar, J; Campos Balea, B; Cumplido Buron, D; Cerezo Gonzalez, S; Diaz, A; Guirado, M; Mielgo Rubio, X; Juan Vidal, OJ; Saigi Morgui, M; Provencio Pulla, M

Real-World Testing Practices, Treatment Patterns and Clinical Outcomes in Patients from Central Eastern Europe with EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Retrospective Chart Review Study (REFLECT)

来自中东欧的 EGFR 突变晚期非小细胞肺癌患者的真实世界检测实践、治疗模式和临床结果:一项回顾性病历审查研究 (REFLECT)

Janžič, Urška; Turnšek, Nina; Dediu, Mircea; Donev, Ivan Shterev; Lupu, Roxana; Teodorescu, Gabriela; Ciuleanu, Tudor E; Pluzanski, Adam

Real-World Journey of Unresectable Stage III NSCLC Patients: Current Dilemmas for Disease Staging and Treatment

不可切除的III期非小细胞肺癌患者的真实世界诊疗历程:疾病分期和治疗的当前困境

Agbarya, Abed; Shalata, Walid; Addeo, Alfredo; Charpidou, Andriani; Cuppens, Kristof; Brustugun, Odd Terje; Rajer, Mirjana; Jakopovic, Marco; Marinca, Mihai V; Pluzanski, Adam; Hiltermann, Jeroen; Araújo, António

Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer

CheckMate 017 和 057 随机 III 期试验的五年结果:纳武利尤单抗与多西他赛治疗既往接受过治疗的非小细胞肺癌

Borghaei, Hossein; Gettinger, Scott; Vokes, Everett E; Chow, Laura Q M; Burgio, Marco Angelo; de Castro Carpeno, Javier; Pluzanski, Adam; Arrieta, Oscar; Frontera, Osvaldo Arén; Chiari, Rita; Butts, Charles; Wójcik-Tomaszewska, Joanna; Coudert, Bruno; Garassino, Marina Chiara; Ready, Neal; Felip, Enriqueta; García, Miriam Alonso; Waterhouse, David; Domine, Manuel; Barlesi, Fabrice; Antonia, Scott; Wohlleber, Markus; Gerber, David E; Czyzewicz, Grzegorz; Spigel, David R; Crino, Lucio; Eberhardt, Wilfried Enst Erich; Li, Ang; Marimuthu, Sathiya; Brahmer, Julie

Updated Overall Survival in a Randomized Study Comparing Dacomitinib with Gefitinib as First-Line Treatment in Patients with Advanced Non-Small-Cell Lung Cancer and EGFR-Activating Mutations

一项随机研究比较了达克替尼与吉非替尼作为晚期非小细胞肺癌和 EGFR 激活突变患者的一线治疗效果,更新了总体生存率

Tony S Mok, Ying Cheng, Xiangdong Zhou, Ki Hyeong Lee, Kazuhiko Nakagawa, Seiji Niho, Alka Chawla, Rafael Rosell, Jesus Corral, Maria Rita Migliorino, Adam Pluzanski, Kay Noonan, Yiyun Tang, Malaika Pastel, Keith D Wilner, Yi-Long Wu5

Real-world clinical outcomes of first-generation and second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large cohort of European non-small-cell lung cancer patients

一项针对大量欧洲非小细胞肺癌患者的研究,评估了第一代和第二代表皮生长因子受体酪氨酸激酶抑制剂的真实世界临床疗效

Pluzanski, Adam; Krzakowski, Maciej; Kowalski, Dariusz; Dziadziuszko, Rafal